Bristol Myers Squibb to Participate in Wolfe Research’s 2nd Annual Virtual Healthcare Conference
NEW YORK–(BUSINESS WIRE)–Bristol Myers Squibb (NYSE: BMY) today announced that the company will take part in a fireside chat at Wolfe Research’s 2nd Annual Virtual Healthcare Conference, which will be webcast on Wednesday, November 18, 2020. Giovanni Caforio, M.D., Board Chair and Chief Executive Officer will answer questions about the company at 9:15 a.m. EST.
Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. An archived edition of the session will be available later that day.
About Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.
corporatefinancial-news
View source version on businesswire.com: https://www.businesswire.com/news/home/20201111005603/en/
Bristol Myers Squibb
Media:
[email protected]
Investor Relations:
Tim Power
609-252-7509
[email protected]
Nina Goworek
908-673-9711
[email protected]
KEYWORDS: New York New Jersey United States North America
INDUSTRY KEYWORDS: Biotechnology Pharmaceutical Public Relations/Investor Relations General Health Health Infectious Diseases Communications Other Health
MEDIA:
| Logo |
 |